SNYR

MKT CAP:$4M

Synergy CHC Corp.

Market Cap

$4M

Healthcare·Medical - Distribution·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$0.40-$1.48 (-78.56%)

Apr 23, 2026

Company Details

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; lifestyle products and ac...

CEO

Jack Ross

IPO Date

Mar 17, 2014

Website

synergychc.com

Key Metrics TTM

Revenue

$35M

-8.5% YoY

Net Income

$3M

EPS (Diluted)

$0.30

Free Cash Flow

-$7M

Revenue / Share

$3.42

Gross Margin

71.0%

Operating Margin

18.0%

Net Margin

7.5%

FCF Margin

-19.2%

P/S

0.1x

P/E

1.5x

Earnings Reports

FY 2025

Mar 31, 2026

$30M-12.8%EPS -$1.27

Q3 2025

Nov 13, 2025

$8M+12.4%EPS $0.01

Q2 2025

Aug 14, 2025

$8M+1.4%EPS $0.17

Q1 2025

May 15, 2025

$8M-13.2%EPS $0.10

FY 2024

Mar 31, 2025

$35M-18.6%EPS $0.28

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 20	$12M	$8M	$1M
Q4 20	$10M	$6M	-$1M
Q1 21	$12M	$9M	$2M
Q2 21	$12M	$9M	$2M
Q3 21	$12M	$9M	$2M
Q1 23	$8M	$6M	$1M
Q2 23	$11M	$8M	$3M
Q3 23	$11M	$8M	$2M
Q4 23	$13M	$11M	$4M
Q1 24	$9M	$7M	$2M
Q2 24	$8M	$6M	$2M
Q3 24	$7M	$5M	$1M
Q4 24	$10M	$7M	$1M
Q1 25	$8M	$6M	$2M
Q2 25	$8M	$6M	$2M
Q3 25	$8M	$6M	$1M

Valuation

Quarter	P/S	P/E
Q3 20	2.3x	—
Q4 20	1.5x	—
Q1 21	1.0x	50.5x
Q2 21	1.5x	36.5x
Q3 21	1.4x	22.0x
Q1 23	0.6x	5.2x
Q2 23	0.3x	1.8x
Q3 23	0.3x	1.8x
Q4 23	0.3x	1.7x
Q1 24	0.0x	0.1x
Q2 24	0.4x	3.3x
Q3 24	0.5x	3.9x
Q4 24	0.9x	14.9x
Q1 25	0.5x	7.4x
Q2 25	0.7x	7.5x
Q3 25	0.6x	8.3x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 20	-$1M	-$1M
Q3 20	$418.8K	$549.4K
Q4 20	$317.8K	$492.9K
Q1 21	$656.1K	$656.1K
Q2 21	$656.1K	$656.1K
Q3 21	$66.5K	$66.5K
Q1 23	-$1M	-$1M
Q3 23	-$931.1K	-$931.1K
Q4 23	$3M	$3M
Q1 24	-$858.0K	-$858.0K
Q2 24	-$282.0K	-$282.0K
Q3 24	-$237.5K	-$237.5K
Q4 24	-$3M	-$3M
Q1 25	-$822.8K	-$822.8K
Q2 25	-$77.0K	-$77.0K
Q3 25	-$2M	-$2M

Capital Expenditures

Quarter	CapEx
Q1 20	$0
Q3 20	$130.5K
Q4 20	$175.0K
Q1 21	$0
Q2 21	$0
Q3 21	$0
Q1 23	$5
Q3 23	$0
Q4 23	$0
Q1 24	$0
Q2 24	$0
Q3 24	$0
Q4 24	$1
Q1 25	$0
Q2 25	$0
Q3 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 20	+93.3%	+93.4%
Q4 20	+36.9%	+61.2%
Q1 21	+100.1%	+51.4%
Q2 21	+102.4%	+49.5%
Q3 21	-3.7%	-14.6%
Q1 23	-21.0%	-39.6%
Q2 23	-12.8%	-27.6%
Q3 23	-12.7%	-18.7%
Q4 23	+12.1%	-5.5%
Q1 24	+18.2%	+11.6%
Q2 24	-25.6%	-16.4%
Q3 24	-34.1%	-29.8%
Q4 24	-22.3%	+1.4%
Q1 25	-13.2%	-18.2%
Q2 25	+1.4%	+1.1%
Q3 25	+12.4%	+10.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 20	$38.7K	0.6%
Q3 20	$0	0.0%
Q4 20	$0	0.0%
Q1 21	$0	0.0%
Q2 21	$0	0.0%
Q3 21	$0	0.0%
Q1 23	$0	0.0%
Q3 23	$0	0.0%
Q4 23	$0	0.0%
Q1 24	$0	0.0%
Q2 24	$0	0.0%
Q3 24	$4.6K	0.1%
Q4 24	$0	0.0%
Q1 25	$0	0.0%
Q2 25	$0	0.0%
Q3 25	$0	0.0%

OpEx Breakdown

Quarter	G&A	S&M	SG&A
Q3 20	—	—	$7M
Q4 20	—	—	$7M
Q1 21	$1M	$6M	—
Q2 21	$1M	$6M	—
Q3 21	$1M	$5M	—
Q1 23	—	—	$5M
Q2 23	$1M	$3M	—
Q3 23	$1M	$4M	—
Q4 23	$2M	$5M	—
Q1 24	$1M	$4M	—
Q2 24	$903.8K	$3M	—
Q3 24	$1M	$3M	—
Q4 24	$1M	$4M	—
Q1 25	$1M	$3M	—
Q2 25	$2M	$3M	—
Q3 25	$2M	$3M	—

Revenue Segments

Quarter

Revenue by Geography

Quarter	United States	Non-US
Q2 25	$8M	—
Q3 25	$7M	$932.5K

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 20	$821.6K	$0	$821.6K
Q3 20	$1M	$0	$1M
Q4 20	$2M	$0	$2M
Q1 21	$966.4K	$0	$966.4K
Q2 21	$966.4K	$0	$966.4K
Q3 21	$537.0K	$0	$537.0K
Q1 23	$0	$0	$0
Q4 23	$632.5K	$0	$632.5K
Q1 24	$910.7K	$0	$910.7K
Q2 24	$187.3K	$0	$187.3K
Q3 24	$259.4K	$0	$259.4K
Q4 24	$687.9K	$0	$687.9K
Q1 25	$177.9K	$0	$177.9K
Q2 25	$1M	$0	$1M
Q3 25	$1M	$0	$1M
Q4 25	$3M	$0	$3M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 20	90M	-0.0%	0.0%
Q4 20	90M	+0.0%	+0.0%
Q1 21	90M	-0.0%	-0.0%
Q2 21	90M	0.0%	-0.0%
Q3 21	90M	+0.0%	+0.0%
Q1 23	90M	0.0%	0.0%
Q2 23	90M	0.0%	+0.0%
Q3 23	90M	0.0%	+0.0%
Q4 23	90M	0.0%	0.0%
Q1 24	7M	-91.7%	-91.7%
Q2 24	8M	+0.6%	-91.6%
Q3 24	8M	+0.6%	-91.6%
Q4 24	8M	+1.0%	-91.5%
Q1 25	9M	+12.4%	+14.9%
Q2 25	9M	+4.1%	+18.9%
Q3 25	10M	+13.2%	+33.9%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 20	$340.2K	36
Q4 20	$280.0K	36
Q1 21	$343.9K	36
Q2 21	$343.9K	36
Q3 21	$327.7K	36
Q1 23	$221.2K	36
Q2 23	$299.8K	36
Q3 23	$300.2K	36
Q4 23	$367.2K	36
Q1 24	$261.4K	36
Q2 24	$222.9K	36
Q3 24	$198.0K	36
Q4 24	$489.1K	21
Q1 25	$389.1K	21
Q2 25	$387.4K	21
Q3 25	$381.4K	21

Revenue / Employee